David J. Blanchard

Array ( [id] => 11059472 [patent_doc_number] => 20160256433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'Formulations Containing Amorphous Dapagliflozin' [patent_app_type] => utility [patent_app_number] => 14/905990 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14216 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684385 [patent_doc_number] => 20160030530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'SULFORAPHANE/SULFORAPHANE PRECURSOR AND PHYTOSTEROL/PHYTOSTANOL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/775089 [patent_app_country] => US [patent_app_date] => 2014-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13275 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11419963 [patent_doc_number] => 20170028107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'KIND OF ABSORBABLE HIGH STRENGTH AND TOUGHNESS CORROSION-RESISTANT ZINC ALLOY IMPLANT MATERIAL FOR HUMAN BODY' [patent_app_type] => utility [patent_app_number] => 15/102355 [patent_app_country] => US [patent_app_date] => 2014-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1509 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10317158 [patent_doc_number] => 20150202161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'PROCESS FOR MANUFACTURING DRUG DELIVERY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/418690 [patent_app_country] => US [patent_app_date] => 2013-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8704 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464706 [patent_doc_number] => 20120269874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID' [patent_app_type] => utility [patent_app_number] => 13/495701 [patent_app_country] => US [patent_app_date] => 2012-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15239 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13495701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208930 [patent_doc_number] => 20120128581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Sincalide Formulations' [patent_app_type] => utility [patent_app_number] => 13/309848 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15635 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128581.pdf [firstpage_image] =>[orig_patent_app_number] => 13309848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289939 [patent_doc_number] => 20100158920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'FULLY HUMAN ANTIBODIES DIRECTED AGAINST THE HUMAN INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/640671 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 17973 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158920.pdf [firstpage_image] =>[orig_patent_app_number] => 12640671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754712 [patent_doc_number] => 20120027804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'MEDICAL PRODUCT, IN PARTICULAR FOR MANAGEMENT OF TISSUE REPAIR' [patent_app_type] => utility [patent_app_number] => 12/810649 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7397 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027804.pdf [firstpage_image] =>[orig_patent_app_number] => 12810649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574977 [patent_doc_number] => 20100129384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'TACI-IMMUNOGLOBULIN FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/613039 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30147 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129384.pdf [firstpage_image] =>[orig_patent_app_number] => 12613039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594967 [patent_doc_number] => 20100130728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'TACI-IMMUNOGLOBULIN FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/612288 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30145 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130728.pdf [firstpage_image] =>[orig_patent_app_number] => 12612288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451387 [patent_doc_number] => 07964711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same' [patent_app_type] => utility [patent_app_number] => 12/605561 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30159 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964711.pdf [firstpage_image] =>[orig_patent_app_number] => 12605561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374219 [patent_doc_number] => 20090311780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'MINIMALLY IMMUNOGENIC VARIANTS OF SDR-GRAFTED HUMANIZED ANTIBODY CC49 AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/544978 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24944 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311780.pdf [firstpage_image] =>[orig_patent_app_number] => 12544978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4499000 [patent_doc_number] => 07919273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Structural variants of antibodies for improved therapeutic characteristics' [patent_app_type] => utility [patent_app_number] => 12/506992 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 39488 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919273.pdf [firstpage_image] =>[orig_patent_app_number] => 12506992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397840 [patent_doc_number] => 20090317903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'HUMANIZED ANTI-TAG 72 CC49 FOR DIAGNOSIS AND THERAPY OF HUMAN TUMORS' [patent_app_type] => utility [patent_app_number] => 12/474221 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18439 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317903.pdf [firstpage_image] =>[orig_patent_app_number] => 12474221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514252 [patent_doc_number] => 20090214558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'NOVEL MAdCAM ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/429154 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20653 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214558.pdf [firstpage_image] =>[orig_patent_app_number] => 12429154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495358 [patent_doc_number] => 20090263386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'HUMANIZED IMMUNOMODULATORY MONOCLONAL ANTIBODIES FOR THE TREATMENT OF NEOPLASTIC DISEASE OR IMMUNODEFICIENCY' [patent_app_type] => utility [patent_app_number] => 12/406492 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 32197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263386.pdf [firstpage_image] =>[orig_patent_app_number] => 12406492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551822 [patent_doc_number] => 20090285808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'ANTI-CD19 ANTIBODIES AND USES IN ONCOLOGY' [patent_app_type] => utility [patent_app_number] => 12/401310 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 62443 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285808.pdf [firstpage_image] =>[orig_patent_app_number] => 12401310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196351 [patent_doc_number] => 07635767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same' [patent_app_type] => utility [patent_app_number] => 12/359801 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30138 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635767.pdf [firstpage_image] =>[orig_patent_app_number] => 12359801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432612 [patent_doc_number] => 07968688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Antibodies that bind to the C35 polypeptide' [patent_app_type] => utility [patent_app_number] => 12/350937 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 45 [patent_no_of_words] => 137314 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968688.pdf [firstpage_image] =>[orig_patent_app_number] => 12350937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461555 [patent_doc_number] => 07879990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Polynucleotides encoding antibodies that bind to the C35 polypeptide' [patent_app_type] => utility [patent_app_number] => 12/350944 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 45 [patent_no_of_words] => 137475 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879990.pdf [firstpage_image] =>[orig_patent_app_number] => 12350944 [rel_patent_id] =>[rel_patent_doc_number] =>)